tiprankstipranks
Trending News
More News >

Kontafarma China Holdings Ltd Establishes Nomination Committee

Story Highlights
  • Kontafarma China Holdings Ltd forms a Nomination Committee with a focus on gender diversity.
  • The committee will review board structure and make recommendations to enhance governance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Kontafarma China Holdings Ltd Establishes Nomination Committee

Don’t Miss TipRanks’ Half-Year Sale

Kontafarma China Holdings Ltd ( (HK:1312) ) has shared an announcement.

Kontafarma China Holdings Ltd has announced the terms of reference for its Nomination Committee, which will consist of at least three members, primarily independent non-executive directors, with a focus on gender diversity. The committee is tasked with reviewing the board’s structure and composition, assessing the independence of directors, and making recommendations on board appointments and succession planning, thereby enhancing corporate governance and aligning with the company’s strategic objectives.

More about Kontafarma China Holdings Ltd

Average Trading Volume: 1,051,304

Technical Sentiment Signal: Sell

Current Market Cap: HK$156.2M

For a thorough assessment of 1312 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1